KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xenon Pharmaceuticals (XENE) Non-cash Items: 2013-2024

Historic Non-cash Items for Xenon Pharmaceuticals (XENE) over the last 11 years, with Dec 2024 value amounting to $5.9 million.

  • Xenon Pharmaceuticals' Non-cash Items rose 7.10% to $6.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.4 million, marking a year-over-year increase of 7.10%. This contributed to the annual value of $5.9 million for FY2024, which is 23.77% up from last year.
  • Per Xenon Pharmaceuticals' latest filing, its Non-cash Items stood at $5.9 million for FY2024, which was up 23.77% from $4.8 million recorded in FY2023.
  • Xenon Pharmaceuticals' 5-year Non-cash Items high stood at $105.4 million for FY2021, and its period low was $2.4 million during FY2020.
  • Its 3-year average for Non-cash Items is $4.7 million, with a median of $4.8 million in 2023.
  • Per our database at Business Quant, Xenon Pharmaceuticals' Non-cash Items soared by 4,250.98% in 2021 and then slumped by 96.65% in 2022.
  • Over the past 5 years, Xenon Pharmaceuticals' Non-cash Items (Yearly) stood at $2.4 million in 2020, then spiked by 4,250.98% to $105.4 million in 2021, then slumped by 96.65% to $3.5 million in 2022, then spiked by 35.66% to $4.8 million in 2023, then grew by 23.77% to $5.9 million in 2024.